KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Asset Writedowns and Impairment (2016 - 2019)

Quest Diagnostics' Asset Writedowns and Impairment history spans 11 years, with the latest figure at $2.0 million for Q4 2019.

  • For Q4 2019, Asset Writedowns and Impairment fell 50.0% year-over-year to $2.0 million; the TTM value through Dec 2019 reached $11.0 million, up 83.33%, while the annual FY2024 figure was $5.0 million, 400.0% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2019 was $2.0 million at Quest Diagnostics, down from $4.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $86.0 million in Q1 2016 and bottomed at -$235.0 million in Q4 2016.
  • The 5-year median for Asset Writedowns and Impairment is $3.5 million (2017), against an average of $16.4 million.
  • The largest annual shift saw Asset Writedowns and Impairment crashed 461.54% in 2016 before it skyrocketed 133.33% in 2019.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $65.0 million in 2015, then plummeted by 461.54% to -$235.0 million in 2016, then surged by 101.28% to $3.0 million in 2017, then soared by 33.33% to $4.0 million in 2018, then crashed by 50.0% to $2.0 million in 2019.
  • Per Business Quant, the three most recent readings for DGX's Asset Writedowns and Impairment are $2.0 million (Q4 2019), $4.0 million (Q3 2019), and $1.0 million (Q2 2019).